Oxford Vaccine Centre
Newsletters
Be the Future of Health
The Oxford Vaccine Centre is one of the largest clinical trial groups in the UK, conducting research into creating new vaccines as well as improving those that already exist.
Based at the University of Oxford, it is run by the Jenner Institute and the Oxford Vaccine Group.
Subscribe to our Newsletters to find out about the latest research studies.
What are the OVC Newsletters?
OVC periodically sends out newsletters to people who, like you, are interested in taking part in the latest vaccine related research studies. The newsletters keep subscribers up-to-date with volunteering opportunities in new studies and clinical trials, the results from previous studies, and other interesting vaccine information. When you join the newsletter :
- there is no obligation to take part in any study, at any time
- you can unsubscribe from the newsletter at any time
- your information will not be shared with organisations outside the University of Oxford
OVC Newsletter - Adults
If you're over 18 and interested in our studies, subscribe to our adult newsletter below:
OVC Newsletter - Children
If you are a parent interested in your child (under 18) taking part in our studies, or you are a young person aged 16-18 interested in taking part yourself, subscribe to our children's newsletter below:
Who are we?
The Jenner Institute
Based within the Nuffield Department of Medicine, the Jenner Institute brings together investigators who are designing and developing numerous vaccines to generate an exceptional breadth of scientific know-how, whilst still allowing the individual investigators to remain independent and accountable to their funders and stakeholders.
www.jenner.ac.uk Current Jenner Studies
The Oxford Vaccine Group
Based in the Department of Paediatrics, our team of scientists, clinicians and clinical trial staff conduct pre-clinical and clinical studies to develop and improve vaccines. We investigate vaccines for children and adults and cover a breadth of diseases affecting the UK and global populations.Our research has contributed to the introduction of new vaccines to the UK immunisation schedule and has influenced UK and global policy decisions for immunisation.